SAS Offers for Commercial Sphere

Cancer Research Institute BMC

Director: Mgr. Lucia Kučerová PhD.
WWW: http://www.exon.sav.sk
Profile of the Institute: Cancer Research Institute of the Slovak Academy of Sciences belongs to the oldest research institutions in Slovakia. The Institute has been devoted to studies elucidating the reasons, which leads to tumor induction from the early beginning.

In last years the research of new approaches in diagnostics, prevention and management of cancer based on new knowledge about genes, which are involved in tumor induction and growth became dominant. This trend is coming out from traditional Institute’s research fields: retrovirology with emphasis to retroviral vectors, DNA repair, phenotypization of tumor cells by means of monoclonal antibodies, testing of chemical compounds for their potential carcinogenic activity, testing of new chemotherapeutic, and studying factors, which contributes to metastatic potential of tumor cells. In addition the Tumor Registry of Slovak Republic is a part of the Department of tumor epidemiology.

The Institute during its existence (60 years anniversary in 2006), due its achievements became recognized institution in the world. The Institute is member of the Organization of the European Cancer Institutes. The Institute is the editor of the international journal of experimental and clinical oncology NEOPLASMA, one from the best scientific journals edited in Slovakia. The Institute is evaluated by the Slovak Academy of Sciences in the highest A category and is accredited to teach PhD student in two fields, oncology and genetics.

The scientific quality of the Institute is reflected in the successful collaboration with leading institutes all over the world. In the field of oncology, the international collaboration is rather important. The cancer research is multidisciplinary science, where besides physicians other scientist like molecular biologists, chemists, genetics, and other scientists have to be involved. The cancer research is at present more and more oriented to understand molecular mechanisms of tumor cell induction. This knowledge opens the possibility to test heritable predisposition for tumor formation, to develop new ways of therapy based on introduction of genes into tumor cells (gene therapy). These new approaches are of great interest of Institute’s scientists, because they represent new hope for cancer treatment.

Since 1997 the Cancer Research Institute is entrenched in a new building, located close to the clinical departments of the National Cancer Institute in Bratislava. The Cancer Research Institute together with the National Cancer Institute in Bratislava forms an informal Cancer Centre in Slovakia.

Services: IMC-S-00-0071-UEO: Markers detection on neoplastic blood cells (pheno......
IMC-S-00-0072-UEO: Familial Adenomatous Polyposis of Colon (FAP)
IMC-S-00-0073-UEO: Molecular-genetic approaches to the testing of he......
IMC-S-00-0074-UEO: Hereditary predisposition to the breast and ova......
IMC-S-00-0075-UEO: Molecular-genetic testing of hereditary predisposi......
IMC-S-00-0076-UEO: Detection of mutagenicity and carcinogenicity of c......
IMC-S-00-0077-UEO: Flow cytometric functional analysis of multidrug p......
IMC-S-00-0078-UEO: The investigation of bone marrow parablasts in leu......